Literature DB >> 15358473

Factor VII deficiency and its treatment in delivery with recombinant factor VII.

B Pehlivanov1, N Milchev, G Kroumov.   

Abstract

The authors present two cases of pregnant women with coagulation disorders--one with inherited deficiency of factor VII and the second with chronic hepatitis. Both cases were successfully treated with recombinant activated factor VII of coagulation (NovoSeven) in delivery. The advantages of using this product are discussed.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15358473     DOI： 10.1016/j.ejogrb.2003.12.026

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN： 0301-2115            Impact factor:   2.435


  3 in total

1.  The effects of proton radiation on the prothrombin and partial thromboplastin times of irradiated ferrets.

Authors:  Gabriel S Krigsfeld; Jenine K Sanzari; Ann R Kennedy
Journal:  Int J Radiat Biol       Date:  2012-02-06       Impact factor: 2.694

Review 2.  Is prophylaxis required for delivery in women with factor VII deficiency?

Authors:  L M Baumann Kreuziger; Colleen T Morton; Mark T Reding
Journal:  Haemophilia       Date:  2013-04-22       Impact factor: 4.287

3.  AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous hemorrhage.

Authors:  Christopher Binny; Jenny McIntosh; Marco Della Peruta; Hanna Kymalainen; Edward G D Tuddenham; Suzanne M K Buckley; Simon N Waddington; John H McVey; Yunyu Spence; Christopher L Morton; Adrian J Thrasher; John T Gray; Francis J Castellino; Alice F Tarantal; Andrew M Davidoff; Amit C Nathwani
Journal:  Blood       Date:  2011-12-01       Impact factor: 22.113
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.